Select Medical (SEM) to Release Earnings on Thursday

Select Medical (NYSE:SEM - Get Free Report) is anticipated to release its earnings data after the market closes on Thursday, February 20th. Analysts expect Select Medical to post earnings of $0.29 per share and revenue of $1.50 billion for the quarter. Persons that are interested in participating in the company's earnings conference call can do so using this link.

Select Medical Stock Down 0.9 %

Shares of NYSE SEM traded down $0.17 during mid-day trading on Friday, reaching $18.58. 492,206 shares of the company traded hands, compared to its average volume of 706,992. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The stock has a market cap of $2.41 billion, a PE ratio of 8.68, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45. The company's fifty day moving average is $19.19 and its two-hundred day moving average is $28.45. Select Medical has a fifty-two week low of $18.02 and a fifty-two week high of $40.98.

Analyst Ratings Changes

A number of brokerages have recently commented on SEM. Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a report on Monday, November 4th. Benchmark lowered Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. UBS Group lowered their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. Finally, StockNews.com lowered Select Medical from a "buy" rating to a "hold" rating in a report on Thursday. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $39.50.

Insider Buying and Selling at Select Medical

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm's stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares of the company's stock, valued at $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 19.14% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.